By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


UCB, Inc. 

1950 Lake Park Drive

Smyrna  Georgia  30080  U.S.A.
Phone: 770-437-5705 Fax: 770-437-5640



The Medicines Company  Contract manufacturing of Bivalirudin peptide active ingredient

Praecis Pharmaceuticals Incorporated  Contract manufacturing of Abarelix peptide active ingredient

Amgen  Contract manufacturing of Abarelix peptide active ingredient

Bausch & Lomb  Contract manufacturing of active pharmaceutical ingredient

Company News
Important UCB, Inc. (UCBJF.PK) Presence At The 2015 American Academy of Neurology Meeting 4/21/2015 1:20:16 PM
UCB, Inc. (UCBJF.PK) Announces US And EU Regulatory Filings For The Investigational Antiepileptic Drug brivaracetam 1/21/2015 10:05:14 AM
UCB, Inc. (UCBJF.PK) Shows Strong Scientific Presence At Leading Rheumatology Meeting 11/14/2014 8:00:17 AM
UCB, Inc. (UCBJF.PK)-sponsored Data On Cimzia® (certolizumab pegol) To Be Highlighted At American College of Gastroenterology 2014 Annual Scientific Meeting 10/22/2014 11:15:01 AM
MC10 & UCB, Inc. (UCBJF.PK) Partner For Innovative Solutions For Patients With Neurological Disorders 7/28/2014 8:59:03 AM
Wilex AG (WL6.DE) Sends Back Some Promising Drugs To UCB, Inc. (UCBJF.PK) In Effort To Stay Alive 5/22/2014 7:36:33 AM
UCB, Inc. (UCBJF.PK) Announces Data From First Seven Year Evaluation Of Cimzia® (Certolizumab Pegol) In Moderate To Severe Crohn's Disease Patients 5/5/2014 8:54:03 AM
Sanofi (France) (SAN.PA), UCB, Inc. (UCBJF.PK) Strikes $138 Million Pact To Seek Anti-Inflammatory Small Molecules 3/11/2014 7:39:07 AM
UCB, Inc. (UCBJF.PK) CEO Out, Biopharma Chief Appointed To Top Post 2/20/2014 7:25:06 AM
UCB, Inc. (UCBJF.PK) And UK's MRC Technology Sign Exclusive License Agreement For A Fibrosis Program 2/13/2014 9:48:29 AM